{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:05:00Z","timestamp":1783487100505,"version":"3.55.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1097\/01.md.0000123095.65294.34","type":"journal-article","created":{"date-parts":[[2004,3,17]],"date-time":"2004-03-17T09:07:57Z","timestamp":1079514477000},"page":"107-113","source":"Crossref","is-referenced-by-count":65,"title":["Complex Drug-Drug-Disease Interactions Between Amiodarone, Warfarin, and the Thyroid Gland"],"prefix":"10.1097","volume":"83","author":[{"given":"Daniel","family":"Kurnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Loebstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvi","family":"Farfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ezra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillel","family":"Halkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Olchovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210226","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00543320","article-title":"Mechanism of warfarin potentiation by amiodarone: Dose- and concentration-dependent inhibition of warfarin elimination.","volume":"28","author":"Almog","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"R2-3-20210226","first-page":"423","article-title":"Serum interleukin-6 in amiodarone-induced thyrotoxicosis.","volume":"78","author":"Bartalena","year":"1994","journal-title":"J Clin Endocrinol Metabol"},{"key":"R3-3-20210226","first-page":"2930","article-title":"Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: Results of a prospective study.","volume":"81","author":"Bartalena","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-3-20210226","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.0300-0664.2001.01458.x","article-title":"Amiodarone-induced thyrotoxicosis: A difficult diagnostic and therapeutic challenge.","volume":"56","author":"Bartalena","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R5-3-20210226","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/thy.1997.7.541","article-title":"Color flow doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.","volume":"7","author":"Bogazzi","year":"1997","journal-title":"Thyroid"},{"key":"R6-3-20210226","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/endo.134.5.8156930","article-title":"Studies on the in vivo cytotoxic effect of amiodarone.","volume":"134","author":"Chiovato","year":"1994","journal-title":"Endocrinology"},{"key":"R7-3-20210226","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/000992288402300308","article-title":"Potentiation of oral anticoagulant effect by L-thyroxine.","volume":"23","author":"Costigan","year":"1984","journal-title":"Clin Pediatr (Phila)"},{"key":"R8-3-20210226","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00007611-200093050-00001","article-title":"Response to warfarin and other oral anticoagulants: Effects of disease states.","volume":"93","author":"Demirkan","year":"2000","journal-title":"South Med J"},{"key":"R9-3-20210226","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.0300-0664.2001.01457.x","article-title":"Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: Role of colour-flow Doppler sonography.","volume":"56","author":"Eaton","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R10-3-20210226","first-page":"2118","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation: Executive summary.","volume":"104","author":"Fuster","year":"2001","journal-title":"Circulation"},{"key":"R11-3-20210226","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJMsa020703","article-title":"Adverse drug events in ambulatory care.","volume":"16","author":"Gandhi","year":"2003","journal-title":"N Engl J Med"},{"key":"R12-3-20210226","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7326\/0003-4819-126-1-199701010-00009","article-title":"Effects of amiodarone on thyroid function.","volume":"126","author":"Harjai","year":"1997","journal-title":"Ann Intern Med"},{"key":"R13-3-20210226","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/clpt.1992.39","article-title":"The mechanism of the interaction between amiodarone and warfarin in humans.","volume":"51","author":"Heimark","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"R14-3-20210226","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0163-7258(96)00140-4","article-title":"Human P450 metabolism of warfarin.","volume":"73","author":"Kaminsky","year":"1997","journal-title":"Pharmacol Ther"},{"key":"R15-3-20210226","first-page":"43","article-title":"Problems of anticoagulation with warfarin in hyperthyroidism.","volume":"225","author":"Kellett","year":"1986","journal-title":"Q J Med"},{"key":"R16-3-20210226","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1001\/archinte.1988.00380080065018","article-title":"The incidence, magnitude, and time course of the amiodarone-warfarin interaction.","volume":"148","author":"Kerin","year":"1988","journal-title":"Arch Intern Med"},{"key":"R17-3-20210226","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.2042-7158.1984.tb04400.x","article-title":"Binding of amiodarone by serum proteins and the effects of drugs, hormones, and other interacting ligants.","volume":"36","author":"Lalloz","year":"1984","journal-title":"J Pharm Pharmacol"},{"key":"R18-3-20210226","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1067\/mcp.2001.117444","article-title":"Interindividual variability in sensitivity to warfarin-nature or nurture?","volume":"70","author":"Loebstein","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"R19-3-20210226","first-page":"267","article-title":"The biological disappearance rate of prothrombin, factors VII, IX and X from plasma in hypothyroidism, hyperthyroidism and during fever.","volume":"10","author":"Loeliger","year":"1964","journal-title":"Thrombosis Diath Haemorrh"},{"key":"R20-3-20210226","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/pmj.76.893.133","article-title":"Amiodarone-induced thyroid disorders: A clinical review.","volume":"76","author":"Loh","year":"2000","journal-title":"Postgrad Med J"},{"key":"R21-3-20210226","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02157446","article-title":"The effect of thyroid function on the prothrombin time response to warfarin in rats.","volume":"13","author":"Lowenthal","year":"1957","journal-title":"Experientia"},{"key":"R22-3-20210226","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/105072501300176462","article-title":"Iodine-induced hypothyroidism.","volume":"11","author":"Markou","year":"2001","journal-title":"Thyroid"},{"key":"R23-3-20210226","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy.","volume":"101","author":"Martino","year":"1984","journal-title":"Ann Intern Med"},{"key":"R24-3-20210226","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1001\/archinte.1994.00420230115013","article-title":"Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease.","volume":"154","author":"Martino","year":"1994","journal-title":"Arch Intern Med"},{"key":"R25-3-20210226","first-page":"240","article-title":"The effects of amiodarone on the thyroid.","volume":"22","author":"Martino","year":"2001","journal-title":"Endocr Rev"},{"key":"R26-3-20210226","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1056\/NEJM198103123041116","article-title":"Interaction between warfarin sodium and amiodarone.","volume":"304","author":"Martinowitz","year":"1981","journal-title":"N Engl J Med"},{"key":"R27-3-20210226","first-page":"63a","article-title":"Increased sensitivity to warfarin in thyrotoxicosis.","volume":"49","author":"McIntosh","year":"1970","journal-title":"J Clin Invest"},{"key":"R28-3-20210226","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/107424840100600405","article-title":"Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy.","volume":"6","author":"Naganuma","year":"2001","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"R29-3-20210226","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/hrt.79.2.121","article-title":"Amiodarone and the thyroid: A practical guide to the management of thyroid dysfunction induced by amiodarone therapy.","volume":"79","author":"Newman","year":"1998","journal-title":"Heart"},{"key":"R30-3-20210226","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM196201112660205","article-title":"Effect of sodium dextrothyroxine in patients receiving anticoagulants.","volume":"266","author":"Owens","year":"1962","journal-title":"N Engl J Med"},{"key":"R31-3-20210226","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1056\/NEJMra021194","article-title":"Thyroiditis.","volume":"348","author":"Pearce","year":"2003","journal-title":"N Engl J Med"},{"key":"R32-3-20210226","first-page":"513","article-title":"Pharmacokinetics and body distribution of amiodarone in man.","volume":"34","author":"Plomb","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"R33-3-20210226","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-62-3-563","article-title":"Iodine kinetic studies during amiodarone treatment.","volume":"62","author":"Rao","year":"1986","journal-title":"J Clin Endocrinol Metabol"},{"key":"R34-3-20210226","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1136\/bmj.282.6278.1756-a","article-title":"Dangers of amiodarone and anticoagulant treatment.","volume":"282","author":"Rees","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R35-3-20210226","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/105072501300176453","article-title":"Iodine excess and hyperthyroidism.","volume":"11","author":"Roti","year":"2001","journal-title":"Thyroid"},{"key":"R36-3-20210226","first-page":"1247","article-title":"Amiodarone-related cyclic thyroid dysfunction.","volume":"141","author":"Salamon","year":"1989","journal-title":"Can Med Assoc J"},{"key":"R37-3-20210226","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1378\/chest.121.1.19","article-title":"Clinical observations with the amiodarone\/warfarin interaction.","volume":"121","author":"Sanoski","year":"2002","journal-title":"Chest"},{"key":"R38-3-20210226","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.1975.03240230039019","article-title":"Warfarin-induced hypoprothrombinemia: Potentiation by hyperthyroidism.","volume":"231","author":"Self","year":"1975","journal-title":"JAMA"},{"key":"R39-3-20210226","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1161\/01.CIR.96.9.2823","article-title":"Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death.","volume":"96","author":"Sim","year":"1997","journal-title":"Circulation"},{"key":"R40-3-20210226","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00000478-198703000-00004","article-title":"Pathology of the thyroid in amiodarone-associated thyrotoxicosis.","volume":"11","author":"Smyrk","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"R41-3-20210226","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/00007611-198912000-00035","article-title":"Hypothyroidism: Effect on warfarin anticoagulation.","volume":"82","author":"Stephens","year":"1989","journal-title":"South Med J"},{"key":"R42-3-20210226","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","article-title":"Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism.","volume":"91","author":"Trip","year":"1991","journal-title":"Am J Med"},{"key":"R43-3-20210226","first-page":"69","article-title":"Enhancement of warfarin-induced hypoprothrombinemia by thyrotoxicosis.","volume":"131","author":"Vagenakis","year":"1972","journal-title":"Johns Hopkins Med J"},{"key":"R44-3-20210226","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0002-9149(63)90043-2","article-title":"The relationship between thyroid function and anticoagulant therapy.","volume":"11","author":"Walters","year":"1963","journal-title":"Am J Cardiol"},{"key":"R45-3-20210226","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/0003-4819-121-9-199411010-00009","article-title":"Interactions of warfarin with drugs and foods.","volume":"121","author":"Wells","year":"1994","journal-title":"Ann Intern Med"},{"key":"R46-3-20210226","first-page":"273","article-title":"The effects of dextrothyroxine on the kinetics of prothrombin activity: Proposed mechanism of the potentiation of warfarin by D-thyroxine.","volume":"81","author":"Wintraub","year":"1973","journal-title":"J Lab Clin Med"},{"key":"R47-3-20210226","first-page":"49","article-title":"Potentiation of warfarin sodium by amiodarone-induced thyrotoxicosis.","volume":"170","author":"Woeber","year":"1999","journal-title":"West J Med"},{"key":"R48-3-20210226","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0021-9258(18)57335-X","article-title":"Plasma inorganic iodide as a homeostatic regulator of thyroid function.","volume":"174","author":"Wolff","year":"1948","journal-title":"J Biol Chem"},{"key":"R49-3-20210226","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/endo-45-5-504","article-title":"Temporary nature of inhibitory action of excess iodide on organic iodine synthesis in the normal thyroid.","volume":"45","author":"Wolff","year":"1949","journal-title":"Endocrinology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.md.0000123095.65294.34","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:17:24Z","timestamp":1620940644000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-200403000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.md.0000123095.65294.34","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}